menu
    • menu

    Company profile for TME Pharma

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. We specialize in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Our unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms ...
    TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers. We specialize in approaches targeting the tumor microenvironment (TME) in which cancer cells exist. Our unique technology breaks tumor protection barriers against the immune system and blocks tumor repair by neutralizing chemokines in the TME. TME Pharma’s approach works in combination with other forms of treatment to weaken tumor defenses and enable greater therapeutic impact. Our clinical programs in glioblastoma and pancreatic cancer have delivered very promising results and further development is planned.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TME PharmaGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Max-Dohrn-Strasse 8-10 10589 Berlin
    Telephone
    Telephone
    +49 30 726247 0
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tmepharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tme-pharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/tme_pharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TME Pharma Receives In-Principle Bond Extension Agreements
    TME Pharma Receives In-Principle Bond Extension Agreements

    17 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/17/3188821/0/en/TME-Pharma-announces-receipt-of-agreements-in-principle-to-extend-certain-bond-agreements.html

    GLOBENEWSWIRE
    17 Nov 2025
    Share Share
    TME Pharma Publishes Its Semi Annual Results And Half-Year Report
    TME Pharma Publishes Its Semi Annual Results And Half-Year Report

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177870/0/en/TME-Pharma-publishes-its-semi-annual-results-and-half-year-report.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    TME Pharma Completes August Financing and Publishes Cash Position
    TME Pharma Completes August Financing and Publishes Cash Position

    01 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-01/tme-pharma-completes-august-financing-and-publishes-cash-position

    PHARMAWEB
    01 Sep 2025
    Share Share
    TME Pharma Raises €500K via Bond Issue, Notified of Shareholding
    TME Pharma Raises €500K via Bond Issue, Notified of Shareholding

    25 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-25/tme-pharma-to-raise-500k-through-new-bond-issue-and-receives-new-notice-of-shareholding

    PHARMAWEB
    25 Aug 2025
    Share Share
    TME Pharma Receives €2.4M Grant for NOX-A12 Brain Cancer Trial
    TME Pharma Receives €2.4M Grant for NOX-A12 Brain Cancer Trial

    31 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241031648935/en

    BUSINESSWIRE
    31 Oct 2024
    Share Share
    TME Pharma Plans To Externalize And Monetize NOX-E36 Asset
    TME Pharma Plans To Externalize And Monetize NOX-E36 Asset

    22 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240721360607/en

    BUSINESSWIRE
    22 Jul 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search